TL;DR
- NHS halts new child prescriptions at Brighton clinic.
- Investigation found 78 under-18s potentially harmed.
- Concerns over lack of proper medical checks.
- Trans advocacy groups condemn withdrawal of treatment.
- Young trans patients face uncertain healthcare future.
In a shocking turn of events, the NHS has put the brakes on new child prescriptions at the WellBN gender clinic in Brighton, following a year-long safety investigation that uncovered some seriously troubling findings. A staggering 78 under-18s were identified as potentially harmed after being prescribed puberty blockers and cross-sex hormones without the necessary checks. Talk about a medical mess!
According to the NHS investigation, over 20 children received medications without even a face-to-face appointment between February 2023 and December 2025. Blood tests? Forget about it! The overall risk to these young patients was high, and the actual harm is hard to quantify, largely due to shoddy record-keeping. Yikes!
Dr. Christopher Tibbs, the regional medical director for NHS England, didn’t mince words, stating that young people were placed at a significant risk of harm because clinicians were providing “specialist diagnosis, care and treatment that they were neither qualified, nor commissioned to deliver.” He added, “Under no circumstances should this have happened.”
The inquiry revealed that 44 children aged 16 and under were prescribed drugs designed to delay or suppress puberty, including 12 children under 13 and one as young as 11. Additionally, 51 children aged 16 and under were given cross-sex hormones, with four of them under 13. In 53 of the 78 cases reviewed, there were possible neuro-developmental issues. This is not just a statistic; these are real lives at stake!
So, how did we get here? WellBN opened its transgender health hub in Brighton back in 2020, and by last year, around 2,000 patients had registered, many of whom were from outside the city. But it all came crashing down when families started complaining about the services offered to under-18s, leading to a civil legal case against the clinic and the NHS.
In response to the investigation, NHS England ordered WellBN to stop offering new prescriptions to children and referred several current and former clinicians to medical regulators. One unnamed doctor has even been suspended from working as an NHS GP while the investigations continue. The fallout is just beginning!
Trans advocacy group TransActual has been vocal in its condemnation of the withdrawal of treatment from young people. They stated, “We are disturbed to learn that trans young people receiving gender-affirming care through WellBN recently received a letter announcing that their access to endocrine care will be withdrawn at the end of July.”
For those over 16, this means being referred to an NHS CYP gender service with no guarantee of continuing hormone treatment. For those under 16, it’s a bleak outlook with no prospect of hormone treatment until they reach 18, and no assurance of access to puberty blockers. It’s a healthcare crisis for these young trans individuals!
Despite many young trans patients reporting positive experiences with WellBN, the investigation was launched in response to legal action from a parent unhappy with their child’s transition care. This raises serious questions about the future of trans youth healthcare in the UK.
In a country where specialist NHS gender services are typically provided by commissioned providers rather than standard GP practices, this restructuring has left many trans individuals in limbo. With long waits and poor service provision, the concerns raised by advocates are more relevant than ever.
As the dust settles on this investigation, one thing is clear: trans youth deserve access to timely, affirming healthcare, free from political interference. The fight for their rights continues, and we’re here to keep you updated on every twist and turn in this ongoing saga.
https://twitter.com/share?text=https://www.thepinknews.com/2026/06/12/brighton-gp-gender-clinic/